- Home
- OBIO vs OGI Comparison
OBIO vs OGI Comparison
Compare OBIO & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- OGI
- Stock Information
- Founded
- OBIO 2017
- OGI 2013
- Country
- OBIO United States
- OGI Canada
- Employees
- OBIO N/A
- OGI N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- OGI Biotechnology: Pharmaceutical Preparations
- Sector
- OBIO Health Care
- OGI Health Care
- Exchange
- OBIO Nasdaq
- OGI Nasdaq
- Market Cap
- OBIO 151.3M
- OGI 135.1M
- IPO Year
- OBIO N/A
- OGI N/A
- Fundamental
- Price
- OBIO $2.85
- OGI $1.07
- Analyst Decision
- OBIO Strong Buy
- OGI
- Analyst Count
- OBIO 5
- OGI 0
- Target Price
- OBIO $15.00
- OGI N/A
- AVG Volume (30 Days)
- OBIO 69.1K
- OGI 484.7K
- Earning Date
- OBIO 05-12-2025
- OGI 05-13-2025
- Dividend Yield
- OBIO N/A
- OGI N/A
- EPS Growth
- OBIO N/A
- OGI N/A
- EPS
- OBIO N/A
- OGI N/A
- Revenue
- OBIO $2,638,000.00
- OGI $115,451,336.00
- Revenue This Year
- OBIO $27.37
- OGI $50.11
- Revenue Next Year
- OBIO $42.68
- OGI $16.16
- P/E Ratio
- OBIO N/A
- OGI N/A
- Revenue Growth
- OBIO N/A
- OGI N/A
- 52 Week Low
- OBIO $2.49
- OGI $0.85
- 52 Week High
- OBIO $8.87
- OGI $2.17
- Technical
- Relative Strength Index (RSI)
- OBIO 36.86
- OGI 52.89
- Support Level
- OBIO $2.75
- OGI $1.02
- Resistance Level
- OBIO $3.26
- OGI $1.11
- Average True Range (ATR)
- OBIO 0.48
- OGI 0.07
- MACD
- OBIO -0.01
- OGI 0.02
- Stochastic Oscillator
- OBIO 16.82
- OGI 84.62
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.